secondgeneration nonsteroidal antiandrogen nsaa developed treatment prostate cancer never acts potent selective silent antagonist androgen receptor drug diarylthiohydantoin closely related enzalutamide enzalutamide show higher affinity ar firstgeneration nsaa bicalutamide lower affinity dihydrotestosterone dht major endogenous ligand receptor prostate enzalutamide developed together derived nonsteroidal androgen derived firstgeneration nsaa enzalutamide selected lead compounds group compounds synthesized assayed antiandrogenic enzalutamide ultimately selected two clinical development eventually also closely related apalutamide two compounds differing replacement single atom carbon atom one phenyl rings swapped nitrogen atom apalutamide apalutamide approved treatment prostate cancer drug article relating genitourinary system stub help wikipedia expanding